TFEB and melanoma: Consistently, TFEB-disrupted clones, which showed decreased autophagy-lysosome activity, displayed higher resistance to BRAFi treatment and increased treatment-associated metastasis and dedifferentiation [41••], suggesting that impaired autophagy-lysosomal response may be causally related to drug resistance in at least in BRAFV600E melanomas.